Collecting data and samples from women undergoing routine mammograms for breast cancer research
Official title: MERIT (Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies) Cohort
Run by M.D. Anderson Cancer Center · NCT03408353 · Data updated 2026-11-12
This study is collecting health information and blood samples from 10,000 women getting routine mammograms to help researchers learn more about breast cancer and women's health over time.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 25 Years to 80 Years |
| Sex | Women only |
| Enrollment | 10000 (estimated) |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Locations | 1 site (Houston, Texas) |
| Status | Recruiting |
| Started | September 15, 2017 |
| Main results expected | April 30, 2027 |
| Study ends | April 30, 2027 |
| Registry record updated | August 11, 2026 |
| Trial ID | NCT03408353 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women who are undergoing routine screening mammograms and are willing to participate in the study by providing blood samples and completing questionnaires.
✕Probably not a fit
Patients with a personal history of breast cancer or other cancers treated within the last five years may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to establish a longitudinal cohort of 10,000 women who undergo routine annual mammography screening, with follow-up for at least five years or until a breast cancer diagnosis occurs. Participants will complete questionnaires about their personal and family cancer history, health status, and lifestyle factors, and will provide blood samples at baseline and annually. The study will create a repository of blood specimens and a comprehensive database of imaging and clinical data to facilitate future research on breast cancer and women's health.
Why it matters
Potential benefit: If successful, this study could enhance early detection and treatment strategies for breast cancer and improve women's health outcomes.
How similar studies have gone: Other studies have shown success in using similar approaches for biomarker discovery and risk assessment in breast cancer.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Willingness to participate in the study and ability to provide informed consent * Willingness to complete a questionnaire and to provide a blood sample at the initial visit and at follow up annual visits * Undergoing a screening mammogram at participating sites. Subjects undergoing routine annual diagnostic mammograms or CEM as part of a screening study are also eligible. Exclusion Criteria: * Current or recent (within the prior 6 months) history of breast feeding * Personal history of breast cancer (ductal breast carcinoma in situ \[DCIS\] or invasive breast cancer) * Personal history of any other cancer (excluding in-situ, stage 0, and non-melanoma skin cancers and other pre-cancerous conditions) treated within the last 5 years.
Where it's running
-
M D Anderson Cancer Center
Houston, Texas, United States Recruiting
Study contacts
- Principal investigator: Jessica W Leung — M.D. Anderson Cancer Center
- Study coordinator: Jessica Leung
- Email: jwleung@mdanderson.org
- Phone: 713-745-4555
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Mobile health navigation to improve breast cancer screening in Kenyan women
This study tests m-Health patient navigation tools to help women in Kenya access breast cancer screening and early detection services.
-
Blended e-Health Program to Help Women with Breast or Gynecologic Cancer Manage Fear of Cancer Progression
This trial tests a blended online and group program to see if it helps women with breast or gynecologic cancer feel less fear that their cancer could grow or spread.
-
Environmental exposure checks in high-risk and early-onset breast cancer care
This study tests how patients and providers feel about using environmental exposure risk data in breast cancer care for women at average/high risk or with early-onset breast cancer.
-
CSF sample collection from people with metastatic breast cancer to see brain metastasis risk
This study tests whether spinal fluid and other samples can help predict brain metastases in adults with metastatic HER2-positive or triple-negative breast cancer who have not yet shown brain involvement.
-
Body composition and outcomes after breast reconstruction
This study will see if detailed body composition measurements can help predict complications after mastectomy with immediate breast reconstruction in adult women.
-
Support tool for women with HR+ breast cancer on long-term endocrine therapy
This study tests a SHIELD web- and app-based portal to help women with hormone receptor–positive breast cancer manage symptoms while on long-term endocrine treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.